Exubrion Therapeutics® Appoints Jennifer Kirk to Board of Directors; Names Her CEO
ALPHARETTA, Ga., March 18, 2025 /PRNewswire/ — Exubrion Therapeutics, the pioneering company behind Synovetin OA®, an innovative injectable treatment that... Read more.
Kiwi Mouse Trap Ranked Among World’s Most Innovative Products
WELLINGTON, New Zealand, March 18, 2025 /PRNewswire/ — Goodnature‘s world-first hi-tech Mouse Trap has been named one of 2025’s most innovative... Read more.
J.S. Held Recognized Among Global Leaders in Enterprise Risk Management
JERICHO, N.Y., March 18, 2025 /PRNewswire/ — In an increasingly uncertain and volatile global landscape, businesses, governments, and investors face a growing... Read more.
Hoth Therapeutics Announces Positive Preclinical Results for HT-KIT in Aggressive Cancer Gastrointestinal Stromal Tumors (GIST). HT-KIT Triggered Significant Tumor Cell Death as Early as 24 Hours Post-treatment
New Data Demonstrates Significant Reduction in Tumor Growth and KIT Expression in Preclinical GIST Models Induction of Tumor Cell Death – HT-KIT triggered significant... Read more.
Spring Health Launches Neurodiversity Hub to Support Employees, Families, and Leaders
New offering delivers tailored mental health care and resources for neurodivergent individuals in the workplace. NEW YORK, March 18, 2025 /PRNewswire/ — Spring... Read more.
TCBP Announces Outsourcing Initiatives, Reducing Burn Rate and Overhead
The company is expected to reduce core operational burn by 55% when compared to 2024 EDINBURGH, Scotland, March 18, 2025 /PRNewswire/ — TC BioPharm (Holdings)... Read more.
Digital Travel Credentials Take Off, Achieving 15% Global Penetration by 2032
LONDON, March 18, 2025 /PRNewswire/ — Digital Travel Credentials (DTCs) are due to become part of the growing identity metasystem worldwide as the newest manifestation... Read more.
Nipocalimab, the first and only investigational treatment to be granted U.S. FDA Breakthrough Therapy designation for the treatment of adults with moderate-to-severe Sjögren’s disease, has now received Fast Track designation
Sjögren’s disease (SjD) is a prevalent, debilitating autoantibody disease with no FDA-approved advanced treatments The Company is actively enrolling... Read more.
Supply & Demand Chain Executive Honors LogicSource Leader, Erik Given, in the 2025 Pros to Know Awards
WESTPORT, Conn., March 18, 2025 /PRNewswire/ — LogicSource, the leader in procurement services and technology solutions, proudly announces that Erik Given,... Read more.
Madison Scientific Closes $7M in Seed Financing
Funds will be used to advance development of the company’s SmartShunt™ System that aims to address current challenges with existing hydrocephalus treatments... Read more.